Watch PMCB. Know when insiders buy.
One email the day a filing lands. Free.
PMCB
PharmaCyte Biotech, Inc.
0.44
−0.02 −3.37%
USD · close Sep 25
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
100
PASS · shorts 100
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $4.7MP/E —DIV YIELD —FCF YIELD —REV TTM $0NET INCOME −$16.1MNET CASH $17.5M52W 0.38 – 1.22SEC XBRL · TTM TO Invalid Date
SEC filings, in plain English
| Filed | Form | What it is | Period | Document |
|---|---|---|---|---|
| Sep 14 | 10-Q | Quarterly report | Jul 31 | open on EDGAR ↗ |
| Jul 29 | 10-K | Annual report | Apr 30 | open on EDGAR ↗ |
| Jul 17 | 4/A | Mar 31 | open on EDGAR ↗ | |
| Jul 17 | 4/A | Mar 31 | open on EDGAR ↗ | |
| Jul 17 | 4/A | Mar 31 | open on EDGAR ↗ | |
| Jul 17 | 4/A | Mar 31 | open on EDGAR ↗ | |
| Apr 2 | 4 | Insider transaction | Mar 31 | open on EDGAR ↗ |
| Apr 2 | 4 | Insider transaction | Mar 31 | open on EDGAR ↗ |
| Apr 2 | 4 | Insider transaction | Mar 31 | open on EDGAR ↗ |
| Apr 2 | 4 | Insider transaction | Mar 31 | open on EDGAR ↗ |
| Apr 2 | 8-K | Current report · Officer or director change, Shareholder vote, Exhibits | Mar 30 | open on EDGAR ↗ |
| Mar 18 | 4 | Insider transaction | Mar 17 | open on EDGAR ↗ |
| Mar 18 | SCHEDULE 13G | — | open on EDGAR ↗ | |
| Mar 17 | 10-Q | Quarterly report | Jan 31 | open on EDGAR ↗ |
| Mar 9 | ARS | ANNUAL REPORT | Apr 30 | open on EDGAR ↗ |
| Mar 9 | DEF 14A | Proxy statement | Mar 30 | open on EDGAR ↗ |
| Feb 27 | PRE 14A | PRELIMINARY PROXY STATEMENT | Mar 30 | open on EDGAR ↗ |
| Feb 13 | SCHEDULE 13G/A | — | open on EDGAR ↗ | |
| Jan 7 | 4 | Insider transaction | Jan 5 | open on EDGAR ↗ |
| Jan 7 | 4 | Insider transaction | Jan 5 | open on EDGAR ↗ |
| Dec 18 | 10-Q | Quarterly report | Oct 31 | open on EDGAR ↗ |
| Dec 15 | NT 10-Q | EXTENSION | Oct 31 | open on EDGAR ↗ |
| Dec 12 | 4 | Insider transaction | Apr 25 | open on EDGAR ↗ |
| Dec 12 | 4 | Insider transaction | Apr 25 | open on EDGAR ↗ |
| Dec 12 | 4 | Insider transaction | Dec 12 | open on EDGAR ↗ |
| Dec 12 | 4 | Insider transaction | Apr 25 | open on EDGAR ↗ |
| Dec 12 | 4 | Insider transaction | Apr 25 | open on EDGAR ↗ |
| Dec 5 | 8-K | Current report · Listing notice | Dec 1 | open on EDGAR ↗ |
| Nov 18 | 4 | Insider transaction | Sep 4 | open on EDGAR ↗ |
| Nov 18 | SCHEDULE 13D/A | — | open on EDGAR ↗ | |
| Nov 18 | 8-K/A | Current report, amended · Exhibits | Sep 2 | open on EDGAR ↗ |
| Nov 7 | SCHEDULE 13G/A | — | open on EDGAR ↗ | |
| Oct 31 | 8-K | Current report · Officer or director change, Shareholder vote, Exhibits | Oct 30 | open on EDGAR ↗ |
| Oct 6 | DEF 14A | Proxy statement | Oct 30 | open on EDGAR ↗ |
| Sep 26 | EFFECT | — | open on EDGAR ↗ | |
| Sep 24 | PRE 14A | PRELIMINARY PROXY STATEMENT | Oct 30 | open on EDGAR ↗ |
| Sep 24 | CORRESP | — | open on EDGAR ↗ | |
| Sep 23 | UPLOAD | — | open on EDGAR ↗ | |
| Sep 17 | S-3 | Shelf registration | — | open on EDGAR ↗ |
| Sep 15 | 10-Q | Quarterly report | Jul 31 | open on EDGAR ↗ |
Straight from the SEC's filing index, cached for six hours. Full history on EDGAR ↗